Ponnal Nambi

3.0k total citations
92 papers, 2.4k citations indexed

About

Ponnal Nambi is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ponnal Nambi has authored 92 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 32 papers in Physiology and 19 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ponnal Nambi's work include Nitric Oxide and Endothelin Effects (25 papers), Receptor Mechanisms and Signaling (24 papers) and Cholesterol and Lipid Metabolism (16 papers). Ponnal Nambi is often cited by papers focused on Nitric Oxide and Endothelin Effects (25 papers), Receptor Mechanisms and Signaling (24 papers) and Cholesterol and Lipid Metabolism (16 papers). Ponnal Nambi collaborates with scholars based in United States, Canada and United Kingdom. Ponnal Nambi's co-authors include Nambi Aiyar, Mark Pullen, David R. Sibley, Elaine Quinet, David P. Brooks, Rameshwar K. Sharma, J R Peters, Hsiao-Ling Wu, Anita Halpern and Dawn Savio and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Biochemistry.

In The Last Decade

Ponnal Nambi

92 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ponnal Nambi United States 29 1.4k 616 564 532 398 92 2.4k
Ronald R. Fiscus United States 31 1.2k 0.9× 802 1.3× 575 1.0× 237 0.4× 402 1.0× 84 2.6k
Jacques Mizrahi Switzerland 27 1.5k 1.0× 541 0.9× 766 1.4× 283 0.5× 158 0.4× 75 2.4k
David Riddell United Kingdom 21 998 0.7× 1.3k 2.1× 451 0.8× 489 0.9× 249 0.6× 43 2.6k
Martin Thoolen United States 25 1.8k 1.3× 254 0.4× 419 0.7× 1.2k 2.3× 581 1.5× 67 3.2k
Kitty Moores United Kingdom 23 1.3k 0.9× 467 0.8× 526 0.9× 444 0.8× 603 1.5× 34 3.0k
Arco Y. Jeng United States 30 1.3k 0.9× 640 1.0× 369 0.7× 363 0.7× 480 1.2× 130 3.6k
S. Nicosia Italy 28 948 0.7× 707 1.1× 546 1.0× 266 0.5× 126 0.3× 89 2.3k
Hiroaki Konishi Japan 25 2.7k 1.9× 425 0.7× 304 0.5× 276 0.5× 275 0.7× 60 3.6k
José M. Lizcano Spain 28 2.9k 2.1× 510 0.8× 337 0.6× 451 0.8× 398 1.0× 72 3.8k
E. J. Cragoe United States 31 1.8k 1.3× 437 0.7× 446 0.8× 165 0.3× 113 0.3× 77 2.7k

Countries citing papers authored by Ponnal Nambi

Since Specialization
Citations

This map shows the geographic impact of Ponnal Nambi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ponnal Nambi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ponnal Nambi more than expected).

Fields of papers citing papers by Ponnal Nambi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ponnal Nambi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ponnal Nambi. The network helps show where Ponnal Nambi may publish in the future.

Co-authorship network of co-authors of Ponnal Nambi

This figure shows the co-authorship network connecting the top 25 collaborators of Ponnal Nambi. A scholar is included among the top collaborators of Ponnal Nambi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ponnal Nambi. Ponnal Nambi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Quinet, Elaine, Michael Basso, Anita Halpern, et al.. (2009). LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse. Journal of Lipid Research. 50(12). 2358–2370. 82 indexed citations
3.
Bernotas, Ronald C., Robert R. Singhaus, David H. Kaufman, et al.. (2008). Biarylether amide quinolines as liver X receptor agonists. Bioorganic & Medicinal Chemistry. 17(4). 1663–1670. 39 indexed citations
4.
DiBlasio-Smith, Elizabeth A., Maya Arai, Elaine Quinet, et al.. (2008). Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. Journal of Translational Medicine. 6(1). 59–59. 34 indexed citations
5.
Nambi, Ponnal, Michael Basso, Liang Chen, et al.. (2007). Abstract 1453: LXR-623, a novel Liver X Receptor modulator, displays neutral lipid effects in Cholesteryl Ester Transfer Protein-expressing species and inhibits atherosclerotic lesion progression in Low Density Lipoprotein receptor knockout mice. Circulation. 116. 3 indexed citations
6.
Quinet, Elaine, Dawn Savio, Anita Halpern, et al.. (2006). Liver X Receptor (LXR)-β Regulation in LXRα-Deficient Mice: Implications for Therapeutic Targeting. Molecular Pharmacology. 70(4). 1340–1349. 102 indexed citations
7.
Parameswaran, Narayanan, et al.. (2004). Okadaic acid stimulates caspase-like activities and induces apoptosis of cultured rat mesangial cells. Molecular and Cellular Biochemistry. 260(1). 7–11. 9 indexed citations
8.
Quinet, Elaine, Dawn Savio, Anita Halpern, et al.. (2004). Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor. Journal of Lipid Research. 45(10). 1929–1942. 109 indexed citations
9.
Nambi, Ponnal & Nambi Aiyar. (2003). G Protein-Coupled Receptors in Drug Discovery. Assay and Drug Development Technologies. 1(2). 305–310. 48 indexed citations
10.
Aiyar, Nambi, Jyoti Disa, Zhaohui Ao, et al.. (2002). Molecular cloning and pharmacological characterization of bovine calcitonin receptor-like receptor from bovine aortic endothelial cells. Biochemical Pharmacology. 63(11). 1949–1959. 15 indexed citations
11.
Pullen, Mark, et al.. (2001). Stimulation of Hyaluronan Synthetase by Platelet-Derived Growth Factor bb in Human Prostate Smooth Muscle Cells. Pharmacology. 62(2). 103–106. 8 indexed citations
12.
Aiyar, Nambi, Jyoti Disa, Khoa Dang, et al.. (2000). Involvement of G protein-coupled receptor kinase-6 in desensitization of CGRP receptors. European Journal of Pharmacology. 403(1-2). 1–7. 51 indexed citations
13.
Parameswaran, Narayanan, W. S. Spielman, David P. Brooks, & Ponnal Nambi. (1999). SB203580 reverses adrenomedullin's effect on proliferation and apoptosis in cultured mesangial cells. European Journal of Pharmacology. 371(1). 75–82. 22 indexed citations
14.
Griswold, Don E., Lenox D. Martin, Laura Davis, et al.. (1999). Endothelin B Receptor Modulates Inflammatory Pain and Cutaneous Inflammation. Molecular Pharmacology. 56(4). 807–812. 68 indexed citations
15.
16.
Willette, Robert N., Julie A. Ellison, Brian Short, et al.. (1998). Effects of Endothelin Receptor Antagonism and Angiotensin-Converting Enzyme Inhibition on Cardiac and Renal Remodeling in the Rat. Journal of Cardiovascular Pharmacology. 31. S277–S283. 4 indexed citations
17.
Brooks, David P., et al.. (1995). Identification and Function of Putative ETB Receptor Subtypes in the Dog Kidney. Journal of Cardiovascular Pharmacology. 26. S322–325. 22 indexed citations
18.
Pullen, Mark, et al.. (1994). Characterization of a Functional Angiotensin II Receptor in <i>Xenopus laevis </i>Heart. Pharmacology. 48(4). 242–249. 8 indexed citations
19.
DiLella, Anthony G., Nabil A. Elshourbagy, Pradip K. Bhatnagar, et al.. (1991). Expression of human preproendothelin-1 cDNA in cos cells results in the production of mature vasoactive endothelin-1. Biochemical and Biophysical Research Communications. 175(2). 697–705. 3 indexed citations
20.
Nambi, Ponnal, Nambi Aiyar, & Rameshwar K. Sharma. (1982). Solubilization of epinephrine‐specific α2‐adrenergic receptors from adrenocortical carcinoma. FEBS Letters. 140(1). 98–102. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald R. Fiscus Breakdown of academic impact, for papers by Jacques Mizrahi Breakdown of academic impact, for papers by David Riddell Breakdown of academic impact, for papers by Martin Thoolen Breakdown of academic impact, for papers by Kitty Moores Breakdown of academic impact, for papers by Arco Y. Jeng Breakdown of academic impact, for papers by S. Nicosia Breakdown of academic impact, for papers by Hiroaki Konishi Breakdown of academic impact, for papers by José M. Lizcano Breakdown of academic impact, for papers by E. J. Cragoe
Rankless by CCL
2026